Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Scientific evidence and the cost of innovations in the health-care system. Die wissenschaftliche Evidenz und der Preis für Innovationen im Gesundheitssystem.
Med. Klin. Intensivmed. Notfmed. 104, 622-630 (2009)
DOI Verlagsversion bestellen
When depicting the relationship between evidence and the cost of an innovation in the health-care system, the overall risks of assessment, the redistribution of risks in a regulated market, and the ethical consequences must first be taken into account. There are also evidence-based criteria and economic considerations which are relevant when calculating the cost of an innovation. These topics can indicate, but not exhaustively deal with the complicated relationship between scientific evidence and calculating the cost of an innovation in the health-care system. The following three statements summarize the current considerations in the continuing discussion of this topic: aEuro cent Scientific evidence undoubtedly exists which should be taken into consideration when calculating the cost of an innovation in the health-care system. aEuro cent The existing scientific evidence is, however, not sufficient to reach such a decision. Additional information about the benefit perceived by the patient is required. aEuro cent No standardized method exists to measure this additional information. Therefore, a definition problem also exists in the health-care system when setting a price according to scientific evidence.
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Scientific evidence; Cost calculation; Innovation; Health-care system; technology-assessment; strategies; placebo
ISSN (print) / ISBN 2193-6218
Zeitschrift Medizinische Klinik - Intensivmedizin und Notfallmedizin
Quellenangaben Band: 104, Heft: 8, Seiten: 622-630